Guidance

COVID-19 surveillance and immunity studies

An overview of national surveillance programmes that explain the transmission of COVID-19 and other priority infections and how they are affecting the wider population.

• From: UK Health Security Agency
• Published: 13 October 2020
• Last updated: 21 December 2023 — See all updates

Documents

COVID-19 surveillance and immunity studies up to March 2024

HTML

COVID-19 surveillance and immunity studies up to March 2023

HTML

COVID-19 surveillance and immunity studies up to March 2022

HTML

Details

This guidance of the UK’s COVID-19 surveillance and immunity studies is for healthcare professionals, academics, industry and the general public.

Programmes are managed by the UK Health Security Agency (UKHSA) in collaboration with a number of delivery partners, including the Office for National Statistics (ONS), research, academic and commercial partners.

Published 13 October 2020
Last updated 21 December 2023 + show all updates

1. 21 December 2023

   Added links to Winter CIS: UKHSA publications and Vivaldi social care – UCL to 'COVID-19 surveillance and immunity studies up to March 2024'.

2. 12 December 2023

   Added links with further information to 'COVID-19 surveillance and immunity studies up to March 2024'.

3. 10 November 2023

   Added COVID-19 surveillance and immunity studies up to March 2024.

4. 3 April 2023

   Updated COVID-19 surveillance and immunity studies up to March 2023.

5. 10 March 2023

   Added update on pausing data collection for the COVID-19 Infection Survey.

6. 28 June 2022

   Updated COVID-19 surveillance and immunity studies up to March 2022.

7. 8 June 2022

   Updated 'Living with COVID-19' information under Details.

8. 7 June 2022

   Updated 'COVID-19 surveillance and immunity studies', added 'COVID-19 surveillance and immunity studies up to March 2022'.

9. 31 January 2022

   Added CoMix study.

10. 29 December 2021

    Added information on Schools Infection Survey and PITCH. Added link to COVID-19 paediatric surveillance.

11. 23 December 2021

    Added link to the Vivaldi 3 study: Boosters strongly enhance SARS-CoV-2 antibody and cellular responses in elderly residents in care homes.

12. 10 December 2021

    Added link to the Vivaldi 3 study research findings.

13. 16 September 2021

    Added link to research findings: round 6.

14. 15 July 2021

    Added a link to Lay summaries on the Vivaldi 2 study on the University College London website.

15. 1 July 2021

    Added link to Schools Infection Survey research findings: round 5.

16. 1 July 2021

    Added a link to 'SIREN study - one year on' YouTube video.

17. 28 May 2021

    Updated descriptions for React studies, Vivaldi studies and the Schools Infection Survey to represent their current scope.

18. 23 April 2021

    Added link to 'COVID-19 Schools Infection Survey: round 2'.

19. 19 April 2021

    Updated to add a link to the Vivaldi 2 study research findings.

20. 25 March 2021

    Updated to include FAQs for the Vivaldi study, Schools Infection Survey and the UK Biobank SARS-CoV-2 serology study.

21. 18 March 2021

    Updated to add further reports and documentation on the studies.

22. 18 February 2021

    Information updated to reflect further research findings, additional studies and improvement in scope of existing studies.

23. 15 October 2020

    Links added to the document: press releases to REACT-1 and related content links at the end of the document.

24. 13 October 2020

    First published.